235010: Lipid Panel With LDL:HDL Ratio - Labcorp

Maybe your like

Logins Individuals & Patients Find a Lab View Test Results Pay a Bill Shop for Tests View Individuals & Patients Page Providers Test Finder Provider Login Education & Experts Contact Us View Providers Page Health Systems & Organizations Hospitals & Health Systems Employee Wellness & Testing Managed Care & Payors Resources View Organizations Page Biopharma & Investigators Nonclinical Research Central Laboratory Services Real World Data Order a Kit Contact Us View Biopharma Section

Managing Your Health

Shop for Health Tests
Explore Women's Health
Annual Wellness Guidelines
More

Diseases & Therapeutic Areas

Cancer & Oncology
Neurology
Rheumatology
More

Treatment Modalities & Methods

Cell & Gene Therapies
Precision Medicine
Radiopharmaceuticals
Vaccines
More

Scientific Lab Disciplines

Genetics
Digital Pathology & AI
Toxicology
More

Labs

Diagnostic Reference & Specialty Labs
Nonclinical Labs
Central Labs

Industries

Healthcare
Pharma
Medtech
Crop & Agricultural
Chemical & Environmental
Novel Food Safety Testing

Education, events & experts

About us

News

Careers

Investors

Help

Test Menu

Test Menu Test Menu
Test Menu Search Test Menu Search
New & Updated Tests New & Updated Tests
Test Resources Test Resources Test Resources Test Resources ICD-10 Codes

Home
Test Menu
Search
235010: Lipid Panel With LDL:HDL Ratio

Lipid Panel With LDL:HDL Ratio Test Number 235010Test number copied CPT

80061

Share
Print Include LOINC® in print

Test Details
Specimen Requirements
LOINC®

Test Details

Methodology

See individual tests.

Result Turnaround Time

Within 1 day

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Related Information

Clinical Conditions Associated With Cardiovascular Disease
Clinical Utility Test List
High-density Lipoprotein Cholesterol (HDL-C)
Low-density Lipoprotein Cholesterol (Direct)

Test Includes

Cholesterol, LDL:HDL ratio; lipid panel

Use

Abbreviations used are as follows: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; VLDL-C, very low-density lipoprotein cholesterol. Evaluation of hyperlipidemia as an index to coronary artery disease. Investigation of serum lipids is indicated in those with coronary and other arterial disease, especially when it is premature, and in those with family history of atherosclerosis or of hyperlipidemia. In this sense, the expression “premature” is mostly used to include those with a family history of premature CHD (definite myocardial infarction), or sudden death before 55 years of age in father or other male first-degree relative, or before 65 years of age in mother or other female first-degree relative. Patients with xanthomas should be worked up with lipid panels, but not those with xanthelasmas or xanthofibromas in the sense of dermatofibromas. Those whose fasting serum is lipemic should have a lipid panel, but the serum of a subject with high cholesterol but normal triglyceride is not milky in appearance. The patient with high cholesterol (>240 mg/dL) should have a lipid panel. Patients with cholesterol levels between 200−240 mg/dL plus two other coronary heart disease risk factors should also have a lipid panel.1 In addition to application in programs for evaluation of risk factors for coronary arterial disease, lipid profiling may lead to detection of some cases of hypothyroidism. If a patient has low LDL-C, but very low HDL-C, he/she may still be in jeopardy (Castelli of the Framingham study); therefore, LDL-C:HDL-C ratios are useful. Primary hyperlipoproteinemia includes hypercholesterolemia, a direct risk factor for coronary heart disease. Secondary hyperlipoproteinemias include increases of lipoproteins secondary to hypothyroidism, nephrosis, renal failure, obesity, diabetes mellitus, alcoholism, primary biliary cirrhosis, and other types of cholestasis.

Decreased lipids are found with some cases of malabsorption, malnutrition, advanced liver disease. In abetalipoproteinemia, cholesterol is <70 mg/dL.

Special Instructions

State patient's age and sex on the test request form.

Limitations

Patients with obstructive liver disease may develop lipoprotein abnormalities. Serum lipid factors have not been demonstrated to strongly influence recurrent stenosis following coronary angioplasty, the pathogenesis of which is presently not well understood. LDL cholesterol cannot be calculated if triglyceride is >800 mg/dL.

Specimen Requirements

Specimen

Serum (preferred) or plasma

Volume

1 mL

Minimum Volume

0.7 mL (Note: This volume does not allow for repeat testing.)

Container

Red-top tube, gel-barrier tube, or green-top (lithium heparin) tube. Do not use oxalate, EDTA, or citrate plasma.

Collection Instructions

Separate serum or plasma from cells within 45 minutes of collection. Lipid panels are best avoided for three months following acute myocardial infarction, although cholesterol can be measured in the first 24 hours.

Stability Requirements

Temperature	Period
Room temperature	3 days
Refrigerated	14 days
Frozen	14 days
Freeze/thaw cycles	Stable x2

Storage Instructions

Maintain specimen at room temperature.

Patient Preparation

Patient should be on a stable diet, ideally for two to three weeks prior to collection of blood. Fasting is not necessary for this profile, however fasting for 12 to 14 hours priori to collection of the specimen is recommended where the triglyceride value provides a priori diagnostic information such as screening for familial hypercholesterolemia or early onset heart disease, pancreatitis, or confirming hypertriglyceridemia.

Causes for Rejection

Hemolysis

Footnotes

1. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. Arch Intern Med. 1988 Jan; 148(1):36-69.3422148

LOINC® Map

Order Code	Order Code Name	Order Loinc	Result Code	Result Code Name	UofM	Result LOINC
235010	Lipid Panel With LDL/HDL Ratio	100898-6	001065	Cholesterol, Total	mg/dL	2093-3
235010	Lipid Panel With LDL/HDL Ratio	100898-6	001172	Triglycerides	mg/dL	2571-8
235010	Lipid Panel With LDL/HDL Ratio	100898-6	011817	HDL Cholesterol	mg/dL	2085-9
235010	Lipid Panel With LDL/HDL Ratio	100898-6	011919	VLDL Cholesterol Cal	mg/dL	13458-5
235010	Lipid Panel With LDL/HDL Ratio	100898-6	012059	LDL Chol Calc (NIH)	mg/dL	13457-7
235010	Lipid Panel With LDL/HDL Ratio	100898-6	011923	LDL Calc Comment:	8251-1
235010	Lipid Panel With LDL/HDL Ratio	100898-6	011852	LDL/HDL Ratio	ratio	11054-4
Order Code	235010
Order Code Name	Lipid Panel With LDL/HDL Ratio
Order Loinc	100898-6
Result Code	001065
Result Code Name	Cholesterol, Total
UofM	mg/dL
Result LOINC	2093-3
Order Code	235010
Order Code Name	Lipid Panel With LDL/HDL Ratio
Order Loinc	100898-6
Result Code	001172
Result Code Name	Triglycerides
UofM	mg/dL
Result LOINC	2571-8
Order Code	235010
Order Code Name	Lipid Panel With LDL/HDL Ratio
Order Loinc	100898-6
Result Code	011817
Result Code Name	HDL Cholesterol
UofM	mg/dL
Result LOINC	2085-9
Order Code	235010
Order Code Name	Lipid Panel With LDL/HDL Ratio
Order Loinc	100898-6
Result Code	011919
Result Code Name	VLDL Cholesterol Cal
UofM	mg/dL
Result LOINC	13458-5
Order Code	235010
Order Code Name	Lipid Panel With LDL/HDL Ratio
Order Loinc	100898-6
Result Code	012059
Result Code Name	LDL Chol Calc (NIH)
UofM	mg/dL
Result LOINC	13457-7
Order Code	235010
Order Code Name	Lipid Panel With LDL/HDL Ratio
Order Loinc	100898-6
Result Code	011923
Result Code Name	LDL Calc Comment:
UofM
Result LOINC	8251-1
Order Code	235010
Order Code Name	Lipid Panel With LDL/HDL Ratio
Order Loinc	100898-6
Result Code	011852
Result Code Name	LDL/HDL Ratio
UofM	ratio
Result LOINC	11054-4

Tag » What Color Tube For Lipid Panel